Table of Content



Introduction
Ischemia Reperfusion Injury - Overview
Ischemia Reperfusion Injury - Therapeutics Development
Ischemia Reperfusion Injury - Therapeutics Assessment
Ischemia Reperfusion Injury - Companies Involved in Therapeutics Development
Ischemia Reperfusion Injury - Drug Profiles
Ischemia Reperfusion Injury - Dormant Projects
Ischemia Reperfusion Injury - Discontinued Products
Ischemia Reperfusion Injury - Product Development Milestones
Appendix



List of Figures



Number of Products under Development for Ischemia Reperfusion Injury, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables



Number of Products under Development for Ischemia Reperfusion Injury, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..2), H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Companies, H2 2020 (Contd..2), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Target, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Ischemia Reperfusion Injury - Pipeline by Acelerox LLC, H2 2020
Ischemia Reperfusion Injury - Pipeline by Amyndas Pharmaceuticals LLC, H2 2020
Ischemia Reperfusion Injury - Pipeline by Angion Biomedica Corp, H2 2020
Ischemia Reperfusion Injury - Pipeline by Apollo Therapeutics LLC, H2 2020
Ischemia Reperfusion Injury - Pipeline by Aptorum Group Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by Argenx SE, H2 2020
Ischemia Reperfusion Injury - Pipeline by Axolo Pharma Inc, H2 2020
Ischemia Reperfusion Injury - Pipeline by Balmes Transplantation SAS, H2 2020
Ischemia Reperfusion Injury - Pipeline by Beijing Northland Biotech Co Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by Bolder Biotechnology Inc, H2 2020
Ischemia Reperfusion Injury - Pipeline by Celdara Medical LLC, H2 2020
Ischemia Reperfusion Injury - Pipeline by Cellmid Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by CFM Pharma Holding BV, H2 2020
Ischemia Reperfusion Injury - Pipeline by Corline Biomedical AB, H2 2020
Ischemia Reperfusion Injury - Pipeline by Cypralis Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by Domainex Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by EVAS Therapeutics LLC, H2 2020
Ischemia Reperfusion Injury - Pipeline by Everon Biosciences Inc, H2 2020
Ischemia Reperfusion Injury - Pipeline by Gero Discovery, H2 2020
Ischemia Reperfusion Injury - Pipeline by Gilead Sciences Inc, H2 2020
Ischemia Reperfusion Injury - Pipeline by Glucox Biotech AB, H2 2020
Ischemia Reperfusion Injury - Pipeline by Ischemix Inc, H2 2020
Ischemia Reperfusion Injury - Pipeline by Lee’s Pharmaceutical Holdings Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by LG Chem Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by Limulus Therapeutics Pty Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by Mallinckrodt Plc, H2 2020
Ischemia Reperfusion Injury - Pipeline by Neuroene Therapeutics LLC, H2 2020
Ischemia Reperfusion Injury - Pipeline by New B Innovation Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by New Horizons Pharma Inc, H2 2020
Ischemia Reperfusion Injury - Pipeline by Nour Heart Therapeutics LLC, H2 2020
Ischemia Reperfusion Injury - Pipeline by NuNerve Pty Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by Orion Corp, H2 2020
Ischemia Reperfusion Injury - Pipeline by Pfizer Inc, H2 2020
Ischemia Reperfusion Injury - Pipeline by Pharming Group NV, H2 2020
Ischemia Reperfusion Injury - Pipeline by Proteo Inc, H2 2020
Ischemia Reperfusion Injury - Pipeline by Radikal Therapeutics Inc, H2 2020
Ischemia Reperfusion Injury - Pipeline by Reata Pharmaceuticals Inc, H2 2020
Ischemia Reperfusion Injury - Pipeline by Revive Therapeutics Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by SBI Pharmaceuticals Co Ltd, H2 2020
Ischemia Reperfusion Injury - Pipeline by Stealth BioTherapeutics Corp, H2 2020
Ischemia Reperfusion Injury - Pipeline by TheraSource LLC, H2 2020
Ischemia Reperfusion Injury - Pipeline by United Therapeutics Corp, H2 2020
Ischemia Reperfusion Injury - Pipeline by Young Therapeutics LLC, H2 2020
Ischemia Reperfusion Injury - Dormant Projects, H2 2020
Ischemia Reperfusion Injury - Dormant Projects, H2 2020 (Contd..1), H2 2020
Ischemia Reperfusion Injury - Dormant Projects, H2 2020 (Contd..2), H2 2020
Ischemia Reperfusion Injury - Dormant Projects, H2 2020 (Contd..3), H2 2020
Ischemia Reperfusion Injury - Dormant Projects, H2 2020 (Contd..4), H2 2020
Ischemia Reperfusion Injury - Discontinued Products, H2 2020